After the midterm elections, anti-abortion leaders are increasing pressure on the Trump administration and Republican Congress to act against abortion pills. Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, criticized the election results and called for a delay in Dr. Heidi Overton's confirmation as FDA commissioner unless the administration suspends rules allowing mifepristone to be prescribed via telehealth. The push reflects frustration over perceived inaction on abortion issues and highlights the growing access to abortion pills in the U.S.
Key facts
- Anti-abortion leaders are pressuring the Trump administration after midterm election losses.
- Marjorie Dannenfelser described the election results as a disaster for the anti-abortion movement.
- They are urging a delay in Dr. Heidi Overton's confirmation as FDA commissioner.
- Mifepristone accounts for nearly two-thirds of abortions in the U.S.
- Legal challenges to mifepristone's regulation are ongoing.
A short AI summary in our own words. The reporting belongs to Mother Jones; we don't reproduce it.